Skip to content

Company · founded 2010

GigaGen (United States)

San Francisco, United States · gigagen.com

Manage this page

Citations, last 5 years: 89
Works, last 5 years: 18
h-index: 38
Scientists listed: 9
Grants since 2016: 6

Grants received

2016–2019 · research · R44

Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$749.7kImmunodeficiency and Autoimmune Disorders

2016 · research · R43

Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$40k

2016–2018 · research · R44

Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$750.2kImmunodeficiency and Autoimmune Disorders

2015–2020 · research · R44

Production Technology for Recombinant Intravenous Immunoglobulin

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$1M

2015–2021 · research · R44

Production Technology for Recombinant Intravenous Immunoglobulin

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$1M

2015–2020 · research · R44

Production Technology for Recombinant Intravenous Immunoglobulin

David Scott Johnson · GigaGen (United States) · funded by National Institutes of Health

$1M